Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
| Author | |
|---|---|
| Abstract | :
To study the determinants of the pharmacokinetics (PK) of rituximab (RTX) in patients with ANCA-associated vasculitis (AAV) and its association with clinical outcomes. |
| Year of Publication | :
2018
|
| Journal | :
Rheumatology (Oxford, England)
|
| Date Published | :
2018
|
| ISSN Number | :
1462-0324
|
| URL | :
https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/kex484
|
| DOI | :
10.1093/rheumatology/kex484
|
| Short Title | :
Rheumatology (Oxford)
|
| Download citation |